Case Study 13
ESG Ratings & Strategy for a Precision Medicine Innovator
A leading precision medicine company focused on cancer detection and testing. The company is based in California with revenues over USD500 million.
The business situation
After publishing an inaugural ESG report in 2023, the client required support in enhancing ESG across the business, including conducting a greenhouse gas emissions inventory, understanding external ESG ratings, navigating the evolving ESG landscape, and meeting ongoing stakeholder requests.
Our team's role
- Conducting a comprehensive greenhouse gas emissions inventory across Scope 1, 2, and 3 categories and submission of the client's first response to CDP.
- Evaluating ESG ratings from agencies such as MSCI, ISS ESG, EcoVadis, and Sustainalytics and identifying potential gaps and areas for improvement.
- Strategic planning, project management, and authoring of interim ESG updates to showcase ongoing progress.
- Establishing guidelines for responsible practices across the supply chain, including drafting a supplier code of conduct.
- Supporting the client to understand investor expectations better and address any requests from stakeholders both internally and externally.
- Continuously supporting the client in navigating the evolving ESG regulation landscape.
The value our team added
Through our involvement in the client’s ESG project, we provided tangible value by improving multiple ESG ratings and identifying opportunities for ongoing enhancement. Our focus on aligning our client’s activities with industry best practices and stakeholder expectations was instrumental in efficiently achieving ESG rating improvements.
We also provided end-to-end service in helping the client respond to CDP for the first time to maximize scoring potential.
We continually focused on effective communications to provide the client’s internal (e.g., ESG working group; Board of Directors) and external (e.g., key customers, investors) stakeholders a clear view of the client’s ongoing ESG efforts, reinforcing their commitment to transparency and progress.
Our collaboration took a results-driven approach to ESG, focusing on real impact and strategic progress amidst the dynamic business landscape.
